ES2653646T3 - Diagnóstico para cáncer colorrectal - Google Patents
Diagnóstico para cáncer colorrectal Download PDFInfo
- Publication number
- ES2653646T3 ES2653646T3 ES14178981.8T ES14178981T ES2653646T3 ES 2653646 T3 ES2653646 T3 ES 2653646T3 ES 14178981 T ES14178981 T ES 14178981T ES 2653646 T3 ES2653646 T3 ES 2653646T3
- Authority
- ES
- Spain
- Prior art keywords
- m2pk
- igfbp2
- epcam
- mac2bp
- dkk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2010903140A AU2010903140A0 (en) | 2010-07-14 | Diagnostic for colorectal cancer | |
| AU2010903140 | 2010-07-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2653646T3 true ES2653646T3 (es) | 2018-02-08 |
Family
ID=45468816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES14178981.8T Active ES2653646T3 (es) | 2010-07-14 | 2011-07-14 | Diagnóstico para cáncer colorrectal |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20130345322A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2829881B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6061344B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN103140760B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2011279555B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112013000745B1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK2829881T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2653646T3 (cg-RX-API-DMAC7.html) |
| IN (1) | IN2013CN01129A (cg-RX-API-DMAC7.html) |
| NO (1) | NO2829881T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT2829881T (cg-RX-API-DMAC7.html) |
| RU (1) | RU2013103995A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2012006681A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130345322A1 (en) * | 2010-07-14 | 2013-12-26 | Commonwealth Scientific And Industrial Research Organisation | Diagnostic for colorectal cancer |
| US9141756B1 (en) | 2010-07-20 | 2015-09-22 | University Of Southern California | Multi-scale complex systems transdisciplinary analysis of response to therapy |
| CA2825894C (en) | 2011-02-02 | 2021-11-30 | Amgen Inc. | Prognosis of cancer using a circulating biomarker |
| LT2883057T (lt) | 2012-08-09 | 2019-04-25 | Institut National De La Santé Et De La Recherche Médicale (Inserm) | Širdies nepakankamumo diagnostika |
| GB201218341D0 (en) * | 2012-10-12 | 2012-11-28 | Orign Sciences Ltd | Diagnostic method |
| CA2943827A1 (en) * | 2014-03-28 | 2015-10-01 | Applied Proteomics, Inc. | Protein biomarker profiles for detecting colorectal tumors |
| WO2016008975A1 (en) * | 2014-07-18 | 2016-01-21 | Sanofi | Method for predicting the outcome of a treatment with aflibercept of a patient suspected to suffer from a cancer |
| CN106191215B (zh) * | 2015-04-29 | 2020-03-24 | 中国科学院上海生命科学研究院 | 肌肉萎缩相关的蛋白质分子标记Dkk-3的筛选及其应用 |
| WO2016180335A1 (en) * | 2015-05-12 | 2016-11-17 | Superlab Far East Limited | Methods of determining interferon having direct inhibitory effects on tumors and uses thereof |
| CN105219844B (zh) * | 2015-06-08 | 2018-12-14 | 华夏京都医疗投资管理有限公司 | 一种筛查十一种疾病的基因标志物组合、试剂盒以及疾病风险预测模型 |
| CN105021828B (zh) * | 2015-07-20 | 2017-07-28 | 上海交通大学医学院附属新华医院 | 通过检测三期结直肠肿瘤患者血清预测肿瘤患者预后 |
| CN105567846A (zh) * | 2016-02-14 | 2016-05-11 | 上海交通大学医学院附属仁济医院 | 检测粪便中细菌dna的试剂盒及其在大肠癌诊断中的应用 |
| JP6984862B2 (ja) * | 2017-03-15 | 2021-12-22 | 国立大学法人金沢大学 | 血中ケモカインをマーカーとして用いた大腸癌の検出 |
| CN107164535A (zh) * | 2017-07-07 | 2017-09-15 | 沈阳宁沪科技有限公司 | 一种无创高通量甲基化结肠癌诊断、研究和治疗方法 |
| CN110540588B (zh) * | 2018-05-28 | 2022-08-23 | 香港中文大学 | 一种基于肿瘤干细胞标志物EpCAM的抗原表位多肽及其应用 |
| CN108957014A (zh) * | 2018-09-27 | 2018-12-07 | 郑州大学第附属医院 | 结直肠癌血清标志物、表达评估方法、试剂盒及应用 |
| WO2020086729A1 (en) * | 2018-10-23 | 2020-04-30 | Blackthorn Therapeutics, Inc. | Systems and methods for screening, diagnosing, and stratifying patients |
| CN109504778B (zh) * | 2019-01-11 | 2021-11-09 | 复旦大学附属中山医院 | 一种基于表观修饰的5hmC多分子标志物及结直肠癌早期诊断模型 |
| KR102769007B1 (ko) * | 2019-03-01 | 2025-02-14 | 어드밴스드 마커 디스커버리 에스.엘. | 대장암 및/또는 이의 전암 단계 진단을 위한 단백질 시그니처 |
| JP7300660B2 (ja) * | 2019-04-03 | 2023-06-30 | 京都府公立大学法人 | 大腸がんの検出方法 |
| JP7032764B2 (ja) * | 2019-04-03 | 2022-03-09 | 京都府公立大学法人 | 大腸がんの検出方法 |
| GB201906199D0 (en) * | 2019-05-02 | 2019-06-19 | Belgian Volition Sprl | Method for the detection of cancer |
| US20220378877A1 (en) * | 2019-11-13 | 2022-12-01 | University Of Virginia Patent Foundation | Treatment of clostridium difficile infections |
| EP3835789A1 (en) | 2019-12-13 | 2021-06-16 | Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts | Biomarker panel for diagnosing colorectal cancer |
| WO2022130597A1 (ja) * | 2020-12-18 | 2022-06-23 | 国立大学法人東北大学 | 推定装置、推定方法、推定プログラム、生成装置、及び、推定システム |
| WO2022140116A1 (en) * | 2020-12-21 | 2022-06-30 | Freenome Holdings, Inc. | Markers for the early detection of colon cell proliferative disorders |
| KR20240004546A (ko) * | 2021-04-20 | 2024-01-11 | 비전 테크 바이오 피티와이 엘티디 | 결장직장암에 대한 바이오마커 |
| EP4384830A4 (en) * | 2021-08-11 | 2025-09-24 | Vision Tech Bio Pty Ltd | METHOD FOR DETECTING ADENOMA |
| WO2023128419A1 (ko) * | 2021-12-31 | 2023-07-06 | 주식회사 이노제닉스 | 대장암 및 대장 용종 또는 진행 선종의 선별 방법 및 그 응용 |
| WO2023128429A1 (ko) * | 2021-12-31 | 2023-07-06 | 주식회사 이노제닉스 | 대장암 및 진행 선종의 선별 검사 방법 및 그 응용 |
| CN114594259B (zh) * | 2022-04-22 | 2022-09-13 | 北京易科拜德科技有限公司 | 一种新型的用于结直肠癌预后预测和诊断的模型及其应用 |
| PL441319A1 (pl) * | 2022-05-31 | 2023-12-04 | Uniwersytet Medyczny Im. Piastów Śląskich We Wrocławiu | Zestaw biomarkerów białkowych i sposób diagnostyki raka jelita grubego in vitro |
| CN116219007A (zh) * | 2022-09-15 | 2023-06-06 | 绍兴积准生物科技有限公司 | 检测结直肠癌的生物标志物组及其应用 |
| CN119688988A (zh) * | 2024-11-25 | 2025-03-25 | 中国医学科学院肿瘤医院 | Timp1和foxp3作为诊断结直肠癌的生物标志物组合及其应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5925517A (en) | 1993-11-12 | 1999-07-20 | The Public Health Research Institute Of The City Of New York, Inc. | Detectably labeled dual conformation oligonucleotide probes, assays and kits |
| JP2004198419A (ja) * | 2002-12-13 | 2004-07-15 | Bayer Healthcare Llc | Ｔｉｍｐ１を用いた検出方法 |
| US20050014165A1 (en) * | 2003-07-18 | 2005-01-20 | California Pacific Medical Center | Biomarker panel for colorectal cancer |
| EP1664796B1 (en) * | 2003-09-15 | 2010-12-15 | Oklahoma Medical Research Foundation | Method of using cytokine assays to diagnose, treat, and evaluate ankylosing spondylitis |
| BRPI0401830A (pt) | 2004-05-25 | 2006-01-17 | Bentonit Uniao Nordeste Sa | Processo de produção de pós granulados secos |
| US20080112888A1 (en) * | 2006-06-30 | 2008-05-15 | Schering Corporation | Igfbp2 biomarker |
| US9060961B2 (en) | 2006-11-09 | 2015-06-23 | University Of Washington | Molecules and methods for treatment and detection of cancer |
| US9353415B2 (en) * | 2006-12-19 | 2016-05-31 | Thomson Reuters (Scientific) Llc | Methods for functional analysis of high-throughput experimental data and gene groups identified therefrom |
| US20080221056A1 (en) | 2007-02-12 | 2008-09-11 | Johns Hopkins University | Early Detection and Prognosis of Colon Cancers |
| DK2472264T3 (en) * | 2007-02-27 | 2016-02-29 | Sentoclone Internat Ab | Multiplekspåvisning of tumor cells using a panel of agents which bind to extracellular markers |
| WO2008116178A2 (en) * | 2007-03-21 | 2008-09-25 | Vanderbilt University | Systems and methods for diagnosis and prognosis of colorectal cancer |
| JP2010526995A (ja) * | 2007-05-10 | 2010-08-05 | エフ．ホフマン−ラ ロシュ アーゲー | 結腸直腸癌のマーカーとしてのｔｉｍｐ−１の使用 |
| US8492328B2 (en) * | 2007-05-17 | 2013-07-23 | Bristol-Myers Squibb Company | Biomarkers and methods for determining sensitivity to insulin growth factor-1 receptor modulators |
| CA2688558A1 (en) * | 2007-06-04 | 2009-03-26 | Diagnoplex | Biomarker combinations for colorectal cancer |
| US20090017463A1 (en) * | 2007-07-10 | 2009-01-15 | Vanderbilt University | Methods for predicting prostate cancer recurrence |
| EP2271775A4 (en) * | 2008-04-08 | 2011-09-07 | Nuclea Biomarkers Llc | BIOMARKERGROUP FOR PREDICTING THE REPRESENTATION OF COLORECTAL CARCINOMA |
| US20100111969A1 (en) * | 2008-10-31 | 2010-05-06 | Apogenix Gmbh | Il-4 receptor and il-13 as prognostic markers for colon and pancreas tumors |
| AU2009322474A1 (en) * | 2008-12-01 | 2011-07-21 | Lifespan Extension Llc | Methods and compositions for altering health, wellbeing, and lifespan |
| US20110236903A1 (en) * | 2008-12-04 | 2011-09-29 | Mcclelland Michael | Materials and methods for determining diagnosis and prognosis of prostate cancer |
| WO2010096674A2 (en) * | 2009-02-20 | 2010-08-26 | The Regents Of The University Of California | A+ biomarker assays |
| US20110177525A1 (en) * | 2010-01-19 | 2011-07-21 | Predictive Biosciences, Inc. | Antibodies and methods of diagnosing diseases |
| US20130345322A1 (en) * | 2010-07-14 | 2013-12-26 | Commonwealth Scientific And Industrial Research Organisation | Diagnostic for colorectal cancer |
-
2011
- 2011-07-14 US US13/809,785 patent/US20130345322A1/en not_active Abandoned
- 2011-07-14 NO NO14178981A patent/NO2829881T3/no unknown
- 2011-07-14 CN CN201180034158.5A patent/CN103140760B/zh active Active
- 2011-07-14 WO PCT/AU2011/000895 patent/WO2012006681A1/en not_active Ceased
- 2011-07-14 DK DK14178981.8T patent/DK2829881T3/en active
- 2011-07-14 RU RU2013103995/15A patent/RU2013103995A/ru not_active Application Discontinuation
- 2011-07-14 IN IN1129CHN2013 patent/IN2013CN01129A/en unknown
- 2011-07-14 PT PT141789818T patent/PT2829881T/pt unknown
- 2011-07-14 BR BR112013000745-1A patent/BR112013000745B1/pt not_active IP Right Cessation
- 2011-07-14 ES ES14178981.8T patent/ES2653646T3/es active Active
- 2011-07-14 CN CN201511009181.5A patent/CN105755112B/zh active Active
- 2011-07-14 EP EP14178981.8A patent/EP2829881B1/en active Active
- 2011-07-14 EP EP11806149.8A patent/EP2593795A4/en not_active Withdrawn
- 2011-07-14 JP JP2013518909A patent/JP6061344B2/ja active Active
- 2011-07-14 AU AU2011279555A patent/AU2011279555B2/en active Active
-
2017
- 2017-03-28 US US15/471,147 patent/US10877039B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2829881A2 (en) | 2015-01-28 |
| CN103140760A (zh) | 2013-06-05 |
| AU2011279555B2 (en) | 2016-10-20 |
| AU2011279555A1 (en) | 2013-01-31 |
| EP2593795A1 (en) | 2013-05-22 |
| NO2829881T3 (cg-RX-API-DMAC7.html) | 2018-01-20 |
| CN105755112A (zh) | 2016-07-13 |
| DK2829881T3 (en) | 2017-12-04 |
| WO2012006681A1 (en) | 2012-01-19 |
| US10877039B2 (en) | 2020-12-29 |
| US20130345322A1 (en) | 2013-12-26 |
| IN2013CN01129A (cg-RX-API-DMAC7.html) | 2015-07-31 |
| EP2593795A4 (en) | 2014-01-22 |
| JP6061344B2 (ja) | 2017-01-18 |
| CN103140760B (zh) | 2016-01-27 |
| BR112013000745A2 (pt) | 2016-05-24 |
| US20170205414A1 (en) | 2017-07-20 |
| EP2829881A3 (en) | 2015-05-13 |
| JP2013533977A (ja) | 2013-08-29 |
| CN105755112B (zh) | 2019-06-07 |
| EP2829881B1 (en) | 2017-08-23 |
| RU2013103995A (ru) | 2014-08-20 |
| PT2829881T (pt) | 2017-11-29 |
| BR112013000745B1 (pt) | 2021-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2653646T3 (es) | Diagnóstico para cáncer colorrectal | |
| ES2841809T3 (es) | Biomarcadores para pronosticar y evaluar el grado de respuesta de sujetos con cáncer de tiroides y de riñón a compuestos de lenvatinib | |
| KR102539897B1 (ko) | 직장암의 선행화학방사선 표준 치료 반응 예측 및 치료 후 예후 예측을 위한 조성물 및 표준 치료 후 예후가 매우 나쁜 환자를 예측하는 방법 및 조성물 | |
| US20100092476A1 (en) | Pancreatic cancer biomarkers | |
| KR102047502B1 (ko) | 포타슘 채널 단백질을 이용한 암 진단용 조성물 | |
| KR102415457B1 (ko) | 폐암 진단용 다중 바이오마커 및 이의 용도 | |
| KR20100126258A (ko) | 부인과 질환을 탐지하기 위한 분석법 | |
| US20140213467A1 (en) | Mucin 5B as a Pancreatic Cyst Fluid Specific Biomarker for Accurate Diagnosis of Mucinous Cysts and Other Markers Useful for Detection of Pancreatic Malignancy | |
| US20130102486A1 (en) | Perp as a prognostic and diagnostic marker for dysplasia and cancer | |
| CN113234830B (zh) | 用于肺癌诊断的产品及用途 | |
| JP5704684B2 (ja) | ＩｇＧ４関連疾患診断用マーカー及びその利用 | |
| ES2436667B1 (es) | Suero biomarcador para diagnosticar el cáncer colorrectal | |
| KR102026252B1 (ko) | 폐 편평상피세포암 바이오마커 및 이를 이용한 폐 편평상피세포암 진단방법 | |
| US20150376723A1 (en) | Prognostic biomarkers for influenza | |
| CN114286942B (zh) | 检测癌症的方法 | |
| KR102136747B1 (ko) | 장형 위암의 예후 진단 마커 | |
| JP7660077B2 (ja) | 診断方法 | |
| Clavijo Maldonado | Evaluación del gen HER-2 como biomarcador en tumor mamario canino: aproximación epidemiológica y bioquímica | |
| JP2008263840A (ja) | 胃ガンの診断又は検出のための組成物及び方法 | |
| CN118604340A (zh) | 血浆自身抗体在早期肺腺癌诊断中的应用 | |
| ES2548653A2 (es) | Método y kit para el diagnóstico de celiaquía | |
| De Cruz | Basic Science Luminal | |
| JP2008206476A (ja) | 腎ガン診断用組成物及び方法 |